Alkermes plc (ALKS) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- Alkermes plc ALKS 41.22 +2.79%
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
Alkermes plc and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. Alkermes plc and Kiniksa Pharmaceuticals International, plc are of similar size ($6.7B and $6.2B). Kiniksa Pharmaceuticals International, plc trades at the lower P/E: 73.4× against 102×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against 10.8%. Kiniksa Pharmaceuticals International, plc has the higher net margin (9.59% vs 3.97%) and the higher return on invested capital (48.9% vs 2.76%). Across the 20 metrics below, Kiniksa Pharmaceuticals International, plc leads on 14 and Alkermes plc on 6.
Valuation
Profitability
| Metric | ALKS | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 84.56% | 89.82% | 53.94% |
| Operating margin | 7.03% | 11.92% | 0.00% |
| Net margin | 3.97% | 9.59% | 0.00% |
| Free cash flow margin | 13.35% | 21.74% | 0.00% |
| Return on equity | 3.85% | 14.04% | (0.40%) |
| Return on assets | 1.99% | 10.36% | (3.32%) |
| Return on invested capital | 2.76% | 48.87% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack